Nicholas J. Geraghty

486 total citations
24 papers, 371 citations indexed

About

Nicholas J. Geraghty is a scholar working on Physiology, Immunology and Hematology. According to data from OpenAlex, Nicholas J. Geraghty has authored 24 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Physiology, 13 papers in Immunology and 6 papers in Hematology. Recurrent topics in Nicholas J. Geraghty's work include Adenosine and Purinergic Signaling (16 papers), Immune Cell Function and Interaction (10 papers) and Hematopoietic Stem Cell Transplantation (6 papers). Nicholas J. Geraghty is often cited by papers focused on Adenosine and Purinergic Signaling (16 papers), Immune Cell Function and Interaction (10 papers) and Hematopoietic Stem Cell Transplantation (6 papers). Nicholas J. Geraghty collaborates with scholars based in Australia, United States and Sweden. Nicholas J. Geraghty's co-authors include Ronald Sluyter, Debbie Watson, Stephen J. Fuller, Justin J. Yerbury, Aleta Pupovac, Mark R. Wilson, Lisa Belfiore, Yee Lian Chew, Neil R. Cashman and Luke McAlary and has published in prestigious journals such as International Journal of Molecular Sciences, Science Advances and Protein Science.

In The Last Decade

Nicholas J. Geraghty

23 papers receiving 369 citations

Peers

Countries citing papers authored by Nicholas J. Geraghty

Since Specialization

Citations

This map shows the geographic impact of Nicholas J. Geraghty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas J. Geraghty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas J. Geraghty more than expected).

Fields of papers citing papers by Nicholas J. Geraghty

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas J. Geraghty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas J. Geraghty. The network helps show where Nicholas J. Geraghty may publish in the future.

Co-authorship network of co-authors of Nicholas J. Geraghty

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas J. Geraghty. A scholar is included among the top collaborators of Nicholas J. Geraghty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas J. Geraghty. Nicholas J. Geraghty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Low Pretreatment CD4+:CD8+ T Cell Ratios and CD39+CD73+CD19+ B Cell Proportions Are Associated with Improved Relapse-Free Survival in Head and Neck Squamous Cell Carcinoma 2023 ·International Journal of Molecular Sciences ·(unknown), (unknown), Nicholas J. Geraghty, (unknown), Debbie Watson, Daniel Brungs, Martin Carolan, Andrew Miller, (unknown), Morteza Aghmesheh, Ronald Sluyter	4
2	A comparison of diet quality and cardiovascular and inflammatory responses between aerobically trained male adults following either a long‐term vegan or omnivorous dietary pattern 2023 ·Nutrition Bulletin ·Joel C. Craddock, Yasmine Probst, Elizabeth P. Neale, Nicholas J. Geraghty, Gregory E. Peoples	5
3	Humanized Mouse Model to Study the P2X7 Receptor in Graft-Versus-Host Disease 2022 ·Methods in molecular biology ·Debbie Watson, (unknown), (unknown), Nicholas J. Geraghty, (unknown), (unknown), (unknown), Ronald Sluyter	8
4	The P2X7 Receptor Antagonist AZ10606120 Does Not Alter Graft-Versus-Host Disease Development and Increases Serum Human Interferon-γ in a Humanized Mouse Model 2022 ·Research Online (University of Wollongong) ·Nicholas J. Geraghty, (unknown), (unknown), Debbie Watson, Ronald Sluyter	3
5	Purinergic Signalling in Allogeneic Haematopoietic Stem Cell Transplantation and Graft-versus-Host Disease 2021 ·International Journal of Molecular Sciences ·(unknown), Nicholas J. Geraghty, (unknown), (unknown), Stephen J. Fuller, Debbie Watson, Ronald Sluyter	9
6	P2X7 receptor antagonism increases regulatory T cells and reduces clinical and histological graft-versus-host disease in a humanised mouse model 2021 ·Clinical Science ·(unknown), Nicholas J. Geraghty, (unknown), (unknown), Debbie Watson, Ronald Sluyter	23
7	Neuroserpin and transthyretin are extracellular chaperones that preferentially inhibit amyloid formation 2021 ·Science Advances ·(unknown), Sandeep Satapathy, Daniel R. Whiten, Megan A. Kelly, Nicholas J. Geraghty, (unknown), Pietro Sormanni, Michele Vendruscolo, Joel N. Buxbaum, Marie Ranson, Mark R. Wilson	11
8	Streptococcus pyogenes M1T1 Variants Induce an Inflammatory Neutrophil Phenotype Including Activation of Inflammatory Caspases 2021 ·Frontiers in Cellular and Infection Microbiology ·Jonathan G. Williams, (unknown), Nicholas J. Geraghty, Jason D. McArthur, (unknown), (unknown), James A. Tsatsaronis, Ronald Sluyter, Martina Sanderson‐Smith	9
9	The P2X7 receptor antagonist JNJ-47965567 administered thrice weekly from disease onset does not alter progression of amyotrophic lateral sclerosis in SOD1G93A mice 2020 ·Purinergic Signalling ·(unknown), (unknown), (unknown), (unknown), Nicholas J. Geraghty, (unknown), (unknown), Bradley J. Turner, Debbie Watson, Justin J. Yerbury, Ronald Sluyter	26
10	Increased P2X7 expression in the gastrointestinal tract and skin in a humanised mouse model of graft-versus-host disease 2020 ·Clinical Science ·(unknown), (unknown), Nicholas J. Geraghty, (unknown), (unknown), Stephen J. Fuller, (unknown), Debbie Watson, Ronald Sluyter	23
11	Comparison of peripheral blood mononuclear cell isolation techniques and the impact of cryopreservation on human lymphocytes expressing CD39 and CD73 2020 ·Purinergic Signalling ·(unknown), Nicholas J. Geraghty, Jonathan G. Williams, (unknown), Daniel Brungs, Martin Carolan, (unknown), Debbie Watson, (unknown), Ronald Sluyter	17
12	Amyotrophic Lateral Sclerosis: Proteins, Proteostasis, Prions, and Promises 2020 ·Frontiers in Cellular Neuroscience ·Luke McAlary, Yee Lian Chew, Jeremy S. Lum, Nicholas J. Geraghty, Justin J. Yerbury, Neil R. Cashman	31
13	Pharmacological blockade of the CD39/CD73 pathway but not adenosine receptors augments disease in a humanized mouse model of graft‐versus‐host disease 2019 ·Immunology and Cell Biology ·Nicholas J. Geraghty, Debbie Watson, Ronald Sluyter	19
14	Altered donor P2X7 activity in human leukocytes correlates with P2RX7 genotype but does not affect the development of graft-versus-host disease in humanised mice 2019 ·Purinergic Signalling ·(unknown), Nicholas J. Geraghty, (unknown), Ronald Sluyter, Debbie Watson	19
15	Increased splenic human CD4+:CD8+ T cell ratios, serum human interferon-γ and intestinal human interleukin-17 are associated with clinical graft-versus-host disease in humanized mice 2019 ·Transplant Immunology ·Nicholas J. Geraghty, Lisa Belfiore, (unknown), Stephen I. Alexander, Ronald Sluyter, Debbie Watson	16
16	The A2A receptor agonist CGS 21680 has beneficial and adverse effects on disease development in a humanised mouse model of graft-versus-host disease 2019 ·International Immunopharmacology ·Nicholas J. Geraghty, (unknown), Debbie Watson, Ronald Sluyter	10
17	Long-term treatment with the P2X7 receptor antagonist Brilliant Blue G reduces liver inflammation in a humanized mouse model of graft-versus-host disease 2018 ·Cellular Immunology ·Nicholas J. Geraghty, Debbie Watson, Ronald Sluyter	21
18	The P2X7 receptor is not essential for development of imiquimod-induced psoriasis-like inflammation in mice 2017 ·Purinergic Signalling ·Nicholas J. Geraghty, Kylie J Mansfield, Stephen J. Fuller, Debbie Watson, Ronald Sluyter	13
19	The P2X7 receptor antagonist Brilliant Blue G reduces serum human interferon-γ in a humanized mouse model of graft-versus-host disease 2017 ·Clinical & Experimental Immunology ·Nicholas J. Geraghty, Lisa Belfiore, Dalam Ly, (unknown), Stephen J. Fuller, Winny Varikatt, Martina Sanderson‐Smith, (unknown), (unknown), Ronald Sluyter, Debbie Watson	37
20	P2X7 receptor in skin biology and diseases 2016 ·Nicholas J. Geraghty, Debbie Watson, (unknown), Ronald Sluyter	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact